exnos
sia ingen pharma - oksimetazolino hidrochloridas - nosies lašai (tirpalas) - 0,5 mg/ml - oxymetazoline
tammex
farmaceutica biochem international s.r.l. - loperamido hidrochloridas - kietosios kapsulės - 2 mg - loperamide
vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemija, mieloidas, ūmus - antinavikiniai vaistai - vyxeos liposomal fluorouracilu ir folino suaugusiųjų su naujai diagnozuota, terapijos susijusių ūminės mieloidinės leukemijos (t-ppp) arba pinigų plovimo su myelodysplasia susiję pokyčiai (aml-mrc).
lysakare
advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - radiacinės traumų - detoxifying agents for antineoplastic treatment - lysakare yra nurodyta sumažinti inkstų spinduliuotės poveikio metu peptidas-receptorių radionuklidų terapija (prrt) su lutetium (177lu) oxodotreotide suaugusiems.
dutasteride/tamsulosin viatris [dutasteride/tamsulosin mylan]
viatris limited - dutasteridas/tamsulozino hidrochloridas - kietosios kapsulės - 0,5 mg/0,4 mg - tamsulosin and dutasteride
acrescent
h. lundbeck a/s - memantine hidrochloridas, donepezil hidrochloridas - alzhaimerio liga - treatment of alzheimers disease.
dutasteride/tamsulosin accord
accord healthcare b.v. - dutasteridas/tamsulozino hidrochloridas - kietosios kapsulės - 0,5 mg/0,4 mg - tamsulosin and dutasteride
aduzin
sandoz d.d. - dutasteridas/tamsulozino hidrochloridas - kietosios kapsulės - 0,5 mg/0,4 mg - tamsulosin and dutasteride
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicino hidrochloridas - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antinavikiniai vaistai - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
azecort [bileni]
viatris healthcare limited - azelastino hidrochloridas/flutikazono propionatas - nosies purškalas (suspensija) - 137 µg/50 µg/dozėje - fluticasone, combinations